India
· Delayed Price · Currency is INR Alivus Life Sciences Statistics
Total Valuation
NSE:ALIVUS has a market cap or net worth of INR 117.58 billion. The enterprise value is 112.66 billion.
| Market Cap | 117.58B |
| Enterprise Value | 112.66B |
Important Dates
The last earnings date was Wednesday, July 23, 2025.
| Earnings Date | Jul 23, 2025 |
| Ex-Dividend Date | Sep 1, 2025 |
Share Statistics
NSE:ALIVUS has 122.68 million shares outstanding. The number of shares has increased by 0.16% in one year.
| Current Share Class | 122.68M |
| Shares Outstanding | 122.68M |
| Shares Change (YoY) | +0.16% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 8.36% |
| Float | 30.78M |
Valuation Ratios
The trailing PE ratio is 23.77 and the forward PE ratio is 21.72. NSE:ALIVUS's PEG ratio is 1.81.
| PE Ratio | 23.77 |
| Forward PE | 21.72 |
| PS Ratio | 4.90 |
| PB Ratio | 4.17 |
| P/TBV Ratio | 4.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.81 |
Enterprise Valuation
| EV / Earnings | 22.73 |
| EV / Sales | 4.69 |
| EV / EBITDA | 16.18 |
| EV / EBIT | 17.82 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | n/a |
| Interest Coverage | 190.86 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 15.13% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 10.89M |
| Profits Per Employee | 2.25M |
| Employee Count | 2,014 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:ALIVUS has paid 1.71 billion in taxes.
| Income Tax | 1.71B |
| Effective Tax Rate | 25.67% |
Stock Price Statistics
| Beta (5Y) | 0.13 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1,009.67 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 39.19 |
| Average Volume (20 Days) | 84,799 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ALIVUS had revenue of INR 24.00 billion and earned 4.96 billion in profits. Earnings per share was 40.32.
| Revenue | 24.00B |
| Gross Profit | 13.37B |
| Operating Income | 6.32B |
| Pretax Income | 6.67B |
| Net Income | 4.96B |
| EBITDA | 6.96B |
| EBIT | 6.32B |
| Earnings Per Share (EPS) | 40.32 |
Balance Sheet
The company has 5.49 billion in cash and 566.06 million in debt, giving a net cash position of 4.92 billion or 40.12 per share.
| Cash & Cash Equivalents | 5.49B |
| Total Debt | 566.06M |
| Net Cash | 4.92B |
| Net Cash Per Share | 40.12 |
| Equity (Book Value) | 28.17B |
| Book Value Per Share | 229.77 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 55.69%, with operating and profit margins of 26.34% and 20.65%.
| Gross Margin | 55.69% |
| Operating Margin | 26.34% |
| Pretax Margin | 27.79% |
| Profit Margin | 20.65% |
| EBITDA Margin | 29.00% |
| EBIT Margin | 26.34% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.52%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 0.52% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.16% |
| Shareholder Yield | 0.36% |
| Earnings Yield | 4.22% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |